Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Registry for kidney health during pregnancy

Official title: Kidney and Pregnancy Registry

Run by Brugmann University Hospital · NCT06067867 · Data updated 2026-11-12

This study is trying to understand how kidney diseases affect pregnancy and the health of mothers by collecting information from women before, during, and after their pregnancies.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment600 (estimated)
SponsorBrugmann University Hospital
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedSeptember 12, 2023
Main results expectedDecember 2043
Study endsDecember 2043
Registry record updatedOctober 5, 2023
Trial IDNCT06067867 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include women of childbearing age with pre-existing kidney damage or related health issues, as well as pregnant women experiencing renal complications.

Probably not a fit

Patients without any kidney issues or those not planning to conceive may not receive benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on women with kidney diseases and their experiences during pregnancy. It focuses on understanding how pre-existing kidney conditions affect pregnancy outcomes and maternal health. The study will extract data from medical files of women at different stages: pre-conception, during pregnancy, and postpartum. By analyzing this data, researchers hope to identify complications and improve care for pregnant women with kidney issues.

Why it matters

Potential benefit: If successful, this study could lead to better management of kidney-related complications during pregnancy, improving outcomes for both mothers and their babies.

How similar studies have gone: While there may be limited studies specifically focused on this registry approach, existing research has highlighted the importance of monitoring kidney health during pregnancy, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Pre-conception consultations

   Woman of childbearing age with:
   * Renal damage (glomerular, tubular disease, renal lithiasis, systemic disease, metabolic diseases, congenital diseases, etc.)
   * Hematological disorders (sickle cell disease)
   * Kidney transplantation
   * High blood pressure (hypertension)
   * Pre-kidney transplant assessment in progress for discussion of contraception and pregnancy after kidney transplantation
   * Preeclampsia
   * Multiple miscarriages
   * IUGR and low birth weight in the fetus
   * Family history of kidney disease
2. Peri-gravid consultations

   Pregnant women with
   * Pre-existing kidney damage
   * De novo renal failure (IR)
   * Proteinuria
   * Hematuria
   * Chronic hypertension
   * Pregnancy hypertension
   * Renal lithiasis
3. Postpartum consultations

Postpartum women with

* Early/late pre-eclampsia
* Eclampsia / Hemolysis Elevated Liver enzymes Low Platelet (HELLP) syndrome
* Pregnancy hypertension
* Postpartum hemorrhage
* De novo renal failure postpartum

Exclusion Criteria:

Male patients Menopausal patients

Where it's running

  • CHU Brugmann
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.